TradingView
DEXWireNews
4 maj 2020 21:54

NantKwest, Inc. $5.50 target price 

Beskrivning

NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA
Kommentarer
spursvestor
I don’t see where it will have good earnings. What’s driving mechanics
Mer